Monthly Nirsevimab Receipt and Intent Reported by Females Aged 18-49 Years Who Have a Baby <8 Months During the RSV Season, United States
Monthly Nirsevimab Monthly Nirsevimab Receipt and Intent Reported by Females Aged 18-49 Years With infants <8 Months During the RSV Season (born since April 1, 2024)
Monthly estimates of receipt and intent for nirsevimab reported by adult females aged 18–49 years with infants under the age of 8 months during the RSV season (born since April 1, 2024) using data from the National Immunization Survey–Adult COVID Module (NIS–ACM). (https://www.cdc.gov/nis/about/). The NIS–ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older. All estimates are based upon parent-reported receipt of nirsevimab.
Querying over HTTP
Splitgraph serves as an HTTP API that lets you run SQL queries directly on
this data to power Web applications. For example:
curl https://data.splitgraph.com/sql/query/ddn \
-H "Content-Type: application/json" \
-d@-<<EOF
{"sql": "
SELECT *
FROM \"cdc-gov/monthly-nirsevimab-receipt-and-intent-reported-by-vdz4-qrri\".\"monthly_nirsevimab_receipt_and_intent_reported_by\"
LIMIT 100
"}
EOFSee the Splitgraph documentation
for more information.
